Awarded: Jul 01, 2021
$2.42 million
In 2021, DDCF announced the 11 subspecialty fellows receiving a total of $2.42 million in grants forthe Doris Duke Physician Scientist Fellowship, which aims to fund the research of clinical investigators at the subspecialty fellowship stage of their careers and to promote the transition of emerging scientists into faculty-level positions. The physician scientists receive $220,000 each over two years.
Leela Davies, MD, PhD
Brigham and Women’s Hospital
Project name: Predictive Antibody Signatures of Tuberculosis Progression
Kevin I. Duan, MD
University of Washington
Project name: Assessing the Value of Post-Discharge Home Oxygen After a COPD Exacerbation
Joline M. Fan, MD, MS
University of California, San Francisco
Project name: Global and Regional Brain Network Properties of Sleep-Wake States as Drivers of Ictogenesis
John Mark B. Gubatan, MD
Stanford University School of Medicine
Project name: Vitamin D Regulation of α4β7+ B Cell Immunophenotypes and Mucosal Antibody Response to Commensal Gut Bacteria in Patients with Inflammatory Bowel Disease
Jonathan D. Herman, MD, PhD
Brigham and Women’s Hospital
Project name: Whole Proteome Antibody Correlates of Protection from Malaria
Adrienne H. Long, MD, PhD
Stanford University School of Medicine
Project name: Understanding Thymic Education of Self-Specific CD8+ T Cells to Guide Development of Novel Cancer Immunotherapies
Jeffrey W. Patterson-Fortin, MD, PhD
Dana-Farber Cancer Institute
Project name: Exploiting Synthetic Lethality in Microhomology Mediated End-Joining for Pancreatic Cancer Treatment
Alexandra Power-Hays, MD
Cincinnati Children’s Hospital Medical Center
Project name: The Alternative Dosing and Prevention of Transfusions (ADAPT) Study: A Prospective Trial of Hydroxyurea to Reduce Blood Transfusion Need in Children with Sickle Cell Anemia in Uganda and an Assessment of Pharmacokinetics-Guided Hydroxyurea Dosing
Nathan H. Raines, MD, MPH
Beth Israel Deaconess Medical Center
Project name: Niacinamide Adenine Dinucleotide (NAD+) Metabolism in Acute Kidney Injury (AKI) Events and Early Chronic Disease Among Individuals at Risk for Chronic Kidney Disease of Nontraditional Cause (CKDnt)
Drew J. Schwartz, MD, PhD
Washington University School of Medicine in St. Louis
Project name: Impact of Antibiotic Prophylaxis and Treatment of Travelers' Diarrhea on the Microbiome, Resistome and Horizontal Gene Transfer
Marina N. Sharifi, MD, PhD
University of Wisconsin School of Medicine and Public Health
Project name: Multiplex Liquid Biopsy as a Novel Biomarker for PI3K Inhibitor Therapies